YM BioSciences (YMI) Narrows Q2 Loss; Revs Lighter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts YMI Hot Sheet
Join SI Premium – FREE
YM BioSciences (NYSE: YMI) reported Q2 EPS of (C$0.06), versus (C$0.14) reported last year. Revenue for the quarter came in at C$380.1 thousand, versus C$521.42 thousand reported last year.
For earnings history and earnings-related data on YM BioSciences (YMI) click here.
For earnings history and earnings-related data on YM BioSciences (YMI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novagold Resources, Inc. (NG) Misses Q3 EPS by 2c
- Starbucks (SBUX) PT Lowered to $105 at UBS as Shares Already Reflect Improved Momentum
- Frontline stock hits 52-week high on oil price surge
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
